Page last updated: 2024-08-26

bosentan anhydrous and Chronic Hepatitis C

bosentan anhydrous has been researched along with Chronic Hepatitis C in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eller, P; Fuschelberger, R; Grander, W; Tilg, H	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Chronic Hepatitis C

Article	Year
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C. European journal of clinical investigation, 2006, Volume: 36 Suppl 3 Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome	2006

Article

Year

Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C.

European journal of clinical investigation, 2006, Volume: 36 Suppl 3

Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome

2006